A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme

Published:2008-07-26 Issue:2 Volume:90 Page:229-235
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Fadul Camilo E.,Kingman Linda S.,Meyer Louise P.,Cole Bernard F.,Eskey Clifford J.,Rhodes C. Harker,Roberts David W.,Newton Herbert B.,Pipas J. Marc

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-008-9655-9.pdf

Reference40 articles.

1. McLendon RE, Halperin EC (2003) Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 98:1745–1748. doi: 10.1002/cncr.11666

2. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi: 10.1056/NEJMoa043330

3. Govindarajan R, Heaton KM, Broadwater R et al (2000) Effect of thalidomide on gastrointestinal toxic effects of irinotecan. Lancet 356:566–567. doi: 10.1016/S0140-6736(00)02586-1

4. Nakatsu S, Kondo S, Kondo Y et al (1997) Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11. Cancer Chemother Pharmacol 39:417–423. doi: 10.1007/s002800050592

5. Friedman HS, Petros WP, Friedman AH et al (1999) Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol 17:1516–1525

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients;Cancers;2024-06-28

2. Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview;Metabolites;2023-04-11

3. Repurposing drugs in glioblastoma;New Insights Into Glioblastoma;2023

4. A Phase Ib Study of the Simmitecan Single Agent and in Combination With 5-Fluorouracil/Leucovorin or Thalidomide in Patients With Advanced Solid Tumor;Frontiers in Pharmacology;2022-07-22

5. A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials;Cancers;2021-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3